Dr. Hilde Riethmüller-Winzen

Longstanding clinical and pre-clinical (quality, pharmacology, toxicology) services for the pharmaceutical industry, biotechnology companies and universities. Support to obtain international marketing authorization approval for a variety of drugs. Presentation, advocation and defense of medicinal products before national and international Health Authorities. Preparation of study files and for the submission to Health Authorities.

Development and registration of endocrinologic new chemical entities in benign and oncological indications

Member of Board of Directors; responsibility for all medical activities (marketing, research, pharmacovigilance, registration)

Set-up of In-House Bed Unit. In-house and international performance of Phase I and IIa trials of research and marketed drugs

Development of new chemical entities, registration of a new and innovative analgesic

Phase I-III trials of research and commercialized antirheumatics and antidepressants

Senior Physician Specialized in Anesthesiology and Intensive Care; Deputize for General Practitioners occasionally for several months

Dept. of Anaesthesiology, Intensive Care and Outpatient Pain Management